new formula
Posted: Sat Jun 05, 2010 5:23 pm
Teva announces positive results from a study assessing a new formulation of Copaxone.
<shortened url>
<shortened url>
Welcome to This is MS, the leading forum for Multiple Sclerosis research and support. Join our friendly community of patients, caregivers, and researchers celebrating over 20 years of delivering hope through knowledge.
https://www.thisisms.com/forum/
Adverse events were reported by 12.5 percent of patients when injecting 20mg/1.0mL and by 18.1 percent of patients when injecting 20mg/0.5mL.